Keyphrases
Nanoparticles
100%
Tumor Development
100%
Tumor Angiogenesis
100%
Fumagillin
100%
Tumor
18%
Neovascularization
18%
Targeted Nanoparticles
18%
Clinical Trials
9%
Neurotoxicity
9%
In Cancer
9%
Angiogenesis
9%
Adenocarcinoma
9%
Tumor Volume
9%
Tumor Size
9%
Cancer Model
9%
Neovasculature
9%
Drug Dosing
9%
Effective Means
9%
Model Trial
9%
Paramagnetic Nanoparticles
9%
T Cell Infiltration
9%
Systemic Dose
9%
MR Molecular Imaging
9%
Peripheral Distribution
9%
Nanoparticle Treatment
9%
Tumor Parenchyma
9%
MetAP2 Inhibitors
9%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Nanoparticle
100%
Fumagillin
100%
Clinical Trial
9%
Neurotoxicity
9%
Adenocarcinoma
9%
Cancer Model
9%
Immunotherapy
9%
Drug Dose
9%
Methionyl Aminopeptidase 2
9%
Material Science
Nanoparticle
100%
Tumor
100%
Magnetic Resonance Imaging
9%
T-Cells
9%
Veterinary Science and Veterinary Medicine
Fumagillin
100%
T Cell
9%